Carregant...
Is suvorexant a better choice than alternative hypnotics?
Suvorexant is a novel dual orexin receptor antagonist (DORA) newly introduced in the U.S. as a hypnotic, but no claim of superiority over other hypnotics has been offered. The manufacturer argued that the 5 and 10 mg starting doses recommended by the FDA might be ineffective. The manufacturer'...
Guardat en:
| Publicat a: | F1000Res |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
F1000Research
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648222/ https://ncbi.nlm.nih.gov/pubmed/26594338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.6845.1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|